Title |
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
|
---|---|
Published in |
BMC Gastroenterology, November 2012
|
DOI | 10.1186/1471-230x-12-162 |
Pubmed ID | |
Authors |
Adriano M Pellicelli, Mario Romano, Tommaso Stroffolini, Ettore Mazzoni, Fabrizio Mecenate, Roberto Monarca, Antonio Picardi, Maria Elena Bonaventura, Cristina Mastropietro, Pascal Vignally, Arnaldo Andreoli, Massimo Marignani, Cecilia D’Ambrosio, Lucia Miglioresi, Lorenzo Nosotti, Olga Mitidieri, Umberto Vespasiani Gentilucci, Claudio Puoti, Giuseppe Barbaro, Angelo Barlattani, Caterina Furlan, Giorgio Barbarini, and for the CLEO Group |
Abstract |
The impact of viral subtype on the rate of sustained virological response (SVR) to antiviral therapy in patients chronically infected with hepatitis C genotype 1 subtype 1a and 1b has not been extensively investigated. The aim of this study is to determine whether the HCV genotype 1 subtypes 1a and 1b respond differently to treatment with PEGylated interferon (PEG-IFN) plus ribavirin. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 40 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 7 | 18% |
Student > Master | 5 | 13% |
Researcher | 4 | 10% |
Professor > Associate Professor | 4 | 10% |
Student > Ph. D. Student | 4 | 10% |
Other | 8 | 20% |
Unknown | 8 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 18 | 45% |
Biochemistry, Genetics and Molecular Biology | 5 | 13% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 10% |
Agricultural and Biological Sciences | 3 | 8% |
Social Sciences | 1 | 3% |
Other | 1 | 3% |
Unknown | 8 | 20% |